Cargando…

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD

BACKGROUND: The blood eosinophil count has been shown to be a promising biomarker for establishing personalised treatment strategies to reduce corticosteroid use, either inhaled or systemic, in chronic obstructive pulmonary disease (COPD). Eosinophil levels seem relatively stable over time in stable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Citgez, Emanuel, van der Palen, Job, van der Valk, Paul, Kerstjens, Huib A M, Brusse-Keizer, Marjolein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354268/ https://www.ncbi.nlm.nih.gov/pubmed/34376399 http://dx.doi.org/10.1136/bmjresp-2021-000960

Ejemplares similares

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study
por: Citgez, Emanuel, et al.
Publicado: (2016)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France
por: Whittaker, Hannah, et al.
Publicado: (2022)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
por: Søyseth, Vidar, et al.
Publicado: (2021)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
por: Suh, Eui-Sik, et al.
Publicado: (2015)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score
por: Echevarria, Carlos, et al.
Publicado: (2019)

Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
por: Stone, Philip W, et al.
Publicado: (2022)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

No association between DNA methylation and COPD in never and current smokers
por: de Vries, Maaike, et al.
Publicado: (2018)

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study
por: McKeever, Tricia M, et al.
Publicado: (2016)

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
por: Echevarria, C, et al.
Publicado: (2017)

Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
por: Stolbrink, Marie, et al.
Publicado: (2019)

Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study
por: Morasert, Thotsaporn, et al.
Publicado: (2020)

Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study
por: Wang, Yuanyuan, et al.
Publicado: (2020)

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD
por: Dicker, Alison J, et al.
Publicado: (2018)

Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey
por: Williams, Parris J, et al.
Publicado: (2022)

Inter-relationships among neutrophilic inflammation, air trapping and future exacerbation in COPD: an analysis of ECOPD study
por: Yang, Huajing, et al.
Publicado: (2023)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation
por: Echevarria, Carlos, et al.
Publicado: (2018)

Specialty COPD care during COVID-19: patient and clinician perspectives on remote delivery
por: Wu, Frances, et al.
Publicado: (2021)

Association between self-reported moderate to vigorous physical activity and the rate of outpatient treated COPD exacerbations: retrospective cohort study
por: Nguyen, Huong Q, et al.
Publicado: (2020)

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial
por: Demeyer, H, et al.
Publicado: (2017)

Are clinical risk scores for COPD useful?
por: Quint, Jennifer K
Publicado: (2015)

Specialist emergency care and COPD outcomes
por: Lane, Nicholas David, et al.
Publicado: (2018)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD
por: Faiz, Alen, et al.
Publicado: (2023)

Angiopoietin-like protein 4 and cardiovascular function in COPD
por: Waschki, B, et al.
Publicado: (2016)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hm4nh6hsgt4mb40d4hsje5o322